Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Current Deferred Revenue (2021 - 2025)

Prothena Corp Public has reported Current Deferred Revenue over the past 5 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $2.7 million for Q4 2025, down 69.9% from a year ago — trailing twelve months through Dec 2025 was $2.7 million (down 69.9% YoY), and the annual figure for FY2025 was $2.7 million, down 69.9%.
  • Current Deferred Revenue for Q4 2025 was $2.7 million at Prothena Corp Public, down from $2.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for PRTA hit a ceiling of $110.2 million in Q2 2021 and a floor of $316000.0 in Q3 2023.
  • Median Current Deferred Revenue over the past 5 years was $9.4 million (2023), compared with a mean of $32.6 million.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 96.73% in 2023 and later skyrocketed 2694.94% in 2024.
  • Prothena Corp Public's Current Deferred Revenue stood at $7.7 million in 2021, then skyrocketed by 49.43% to $11.4 million in 2022, then plummeted by 97.24% to $316000.0 in 2023, then skyrocketed by 2700.63% to $8.8 million in 2024, then crashed by 69.9% to $2.7 million in 2025.
  • The last three reported values for Current Deferred Revenue were $2.7 million (Q4 2025), $2.7 million (Q3 2025), and $5.1 million (Q2 2025) per Business Quant data.